Lipid | Exemestane (n= 20) | Letrozole (n= 20) | Anastrozole (n= 19) | Placebo (n= 20) |
---|---|---|---|---|
LDL-C (mmol/L) | ||||
   Baseline | 4.2 | 4.2 | 4.2 | 3.8 |
   Week 12, % change | -11 | -4.5 | -12 | -6.1 |
   Week 24, % change | -2.6 | -4.2 | -3.0 | 2.4 |
   Week 36, % change | 1.9 | 0.25 | -5.7 | -5.8 |
HDL-C (mmol/L) | ||||
   Baseline, median | 1.4 | 1.5 | 1.4 | 1.4 |
   Week 12, % change | -4.4 | 9.0 | 1.7 | -3.5 |
   Week 24, % change | -13 | -2.4 | -4.4 | -6.3 |
   Week 36, % change | -6.9 | -2.4 | -2.5 | -6.8 |
Total cholesterol (mmol/L) | ||||
   Baseline, median | 6.1 | 6.1 | 6.3 | 5.9 |
   Week 12, % change | -6.8 | -1.8 | -3.7 | -2.6 |
   Week 24, % change | 0.78 | 1.2 | -0.68 | 0.75 |
   Week 36, % change | 1.3 | -1.9 | -5.8 | -6.4 |
Triglycerides (mmol/L) | ||||
   Baseline, median | 1.1 | 1.2 | 1.2 | 1.0 |
   Week 12, % change | -21 | 6.6 | -10 | -1.6 |
   Week 24, % change | 1.7 | 4.6 | 6.3 | -7.0 |
   Week 36, % change | -1.1 | -5.4 | -3.5 | -0.28 |